OnabotulinumtoxinA wear-off in chronic migraine, observational cohort study

This publication has 9 references indexed in Scilit:

• Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains
  Cephalalgia, 2014
• Method of Injection of OnabotulinumtoxinA for Chronic Migraine: A Safe, Well‐Tolerated, and Effective Treatment Paradigm Based on the PREEMPT Clinical Program
  Headache: The Journal of Head and Face Pain, 2010
• OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program
  Headache: The Journal of Head and Face Pain, 2010
• Neutralizing Antibodies and Secondary Therapy Failure After Treatment With Botulinum Toxin Type A
  Clinical Neuropharmacology, 2009
• Subcutaneous Botulinum toxin type A reduces capsaicin-induced trigeminal pain and vasomotor reactions in human skin
  Pain, 2009
• Review of a Proposed Mechanism for the Antinociceptive Action of Botulinum Toxin Type A
  NeuroToxicology, 2005
• Mechanism of Action of Botulinum Toxin Type A in Migraine Prevention: A Pilot Study
  Headache: The Journal of Head and Face Pain, 2004
• Regulation of Calcitonin Gene‐Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy
  Headache: The Journal of Head and Face Pain, 2004
• Procedures for Administering Botulinum Toxin Type A for Migraine and Tension‐type Headache
  Headache: The Journal of Head and Face Pain, 2003